" how valuable is that ability to secure investors, whilst being pre revenue....."I have been on the share register for over 9 years, and know a lot of fellow long term share holders, and also more recent investors, and they all invested on the representations of stockbrokers who have very little to no meaningful communication with PH. In the past, they have had a fair bit of interaction with Leslie, but I have observed that over the last couple of years, she has become increasingly reticient. Certainly, to a man, there is disappointment that Leslie will not provide the sort of transparency that investors get from other Australian biotechs. WMHB's keen observations are entirely diplomatic.
IMU Price at posting:
8.2¢ Sentiment: Hold Disclosure: Held
(20min delay)